Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new page revision label, v3.5.3, was added and the previous v3.5.2 label removed, signaling a minor version update to the study page. This reflects a backend or UI refresh rather than changes to the trial details themselves.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now shows a new revision banner 'Revision: v3.4.2' and removes older funding/operating notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1; removed the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.